Duke University Hospital
Durham, North Carolina, 27710, United States
NCT Number: NCT02988414
Prospective study at Duke University Hospital comparing the Karius Infectious Disease Diagnostic Sequencing Assay to blood culture results in admitted patients with bacteremia/septicemia.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Durham, North Carolina, 27710, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For Endocarditis Cohort:
Exclusion criteria
Time frame: 12 months
Karius, Inc.
Industry
Diagnosis of Bacteremia/Septicemia by the Karius Sequencing-Based Infectious Disease Diagnostic Assay
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04044703
Bacteremia, Bacterial Infections
Sydney, New South Wales, Australia
View Trial DetailsNCT01321879
Bacteremia, Bacterial Infections
Houston, Texas, United States
View Trial DetailsNCT02852902
Bacteremia, Bacterial Infections
Córdoba, Spain
View Trial DetailsNCT02210169
Bacteremia, Bacterial Infections
Sydney, New South Wales, Australia
View Trial Details